Publication | Open Access
DaxibotulinumtoxinA for Injection has a prolonged duration of response in the treatment of glabellar lines: Pooled data from two multicenter, randomized, double-blind, placebo-controlled, phase 3 studies (SAKURA 1 and SAKURA 2)
66
Citations
16
References
2019
Year
DAXI offers a prolonged duration of response for glabellar line reduction and is well tolerated.
| Year | Citations | |
|---|---|---|
Page 1
Page 1